BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McAleese CE, Choudhury C, Butcher NJ, Minchin RF. Hypoxia-mediated drug resistance in breast cancers. Cancer Lett 2021;502:189-99. [PMID: 33278499 DOI: 10.1016/j.canlet.2020.11.045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Cui Q, Liang XL, Wang JQ, Zhang JY, Chen ZS. Therapeutic implication of carbon monoxide in drug resistant cancers. Biochem Pharmacol 2022;:115061. [PMID: 35489394 DOI: 10.1016/j.bcp.2022.115061] [Reference Citation Analysis]
2 Chen Y, Zhang J, Zhang M, Song Y, Zhang Y, Fan S, Ren S, Fu L, Zhang N, Hui H, Shen X. Baicalein resensitizes tamoxifen-resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia-inducible factor-1α. Clin Transl Med 2021;11:e577. [PMID: 34841716 DOI: 10.1002/ctm2.577] [Reference Citation Analysis]
3 Qiao J, Wang M, Cui M, Fang Y, Li H, Zheng C, Li Z, Xu Y, Hua H, Li D. Small-molecule probes for fluorescent detection of cellular hypoxia-related nitroreductase. J Pharm Biomed Anal 2021;203:114199. [PMID: 34130009 DOI: 10.1016/j.jpba.2021.114199] [Reference Citation Analysis]
4 Ren Y, Wu S, Burdette JE, Cheng X, Kinghorn AD. Structural Insights into the Interactions of Digoxin and Na+/K+-ATPase and Other Targets for the Inhibition of Cancer Cell Proliferation. Molecules 2021;26:3672. [PMID: 34208576 DOI: 10.3390/molecules26123672] [Reference Citation Analysis]
5 Altei WF, Pachane BC, Souza C, Marques MMC, Selistre-de-Araújo H. New insights into the discovery of drugs for triple-negative breast cancer metastasis. Expert Opin Drug Discov 2022;:1-12. [PMID: 35179448 DOI: 10.1080/17460441.2022.2039619] [Reference Citation Analysis]